LNTH

#1009
Lantheus Holdings, Inc. - Common Stock
99.3 0 USD
-0.32%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
99.30
99.30
年范围
0.95
103.89
日变化
-0.32%
每月变动
+22.34%
6个月变化
+70.01%
年变化
+77.13%
前一天收盘价
99.6 2
Open
99.3 0
最低价
99.3 0
High
99.3 0
交易量
209
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 6.47 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
19.52
市销率
2.95

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

新闻